# A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer

> **NCT06527300** · PHASE2 · RECRUITING · sponsor: **Zhejiang Wenda Pharma Technology LTD.** · enrollment: 48 (estimated)

## Conditions studied

- Advanced Solid Tumor (Phase 1)

## Interventions

- **DRUG:** NHWD-870 HCl

## Key facts

- **NCT ID:** NCT06527300
- **Lead sponsor:** Zhejiang Wenda Pharma Technology LTD.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-25
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06527300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06527300, "A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06527300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*